COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO
Development of losartan in transdermal formulation is important due to its low oral bioavailability. Optimal transdermal formulation requires transport mechanism understanding. This study was aimed to develop and evaluate compartmental modeling of losartan transdermal transport in vitro to fulfi...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Gadjah Mada
2014-01-01
|
Series: | Indonesian Journal of Pharmacy |
Subjects: | |
Online Access: | http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/16 |
id |
doaj-00e9888542d1480493060e1841c7ea7a |
---|---|
record_format |
Article |
spelling |
doaj-00e9888542d1480493060e1841c7ea7a2020-11-25T00:46:26ZengUniversitas Gadjah MadaIndonesian Journal of Pharmacy2338-94272338-94862014-01-01251313810.14499/indonesianjpharm25iss1pp31COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITROAkhmad Kharis Nugroho0Annas Binnarjo1Arief Rahman Hakim2Yunita Ermawati3Faculty of Pharmacy Universitas Gadjah Mada, Sekip Utara Yogyakarta, 55281 IndonesiaFaculty of Pharmacy Universitas Gadjah Mada, Sekip Utara Yogyakarta, 55281 IndonesiaFaculty of Pharmacy Universitas Gadjah Mada, Sekip Utara Yogyakarta, 55281 IndonesiaFaculty of Pharmacy Universitas Gadjah Mada, Sekip Utara Yogyakarta, 55281 IndonesiaDevelopment of losartan in transdermal formulation is important due to its low oral bioavailability. Optimal transdermal formulation requires transport mechanism understanding. This study was aimed to develop and evaluate compartmental modeling of losartan transdermal transport in vitro to fulfil this demand. Losartan solution (10g/L in 20% propylene glycol) was filled into the acceptor phase of a vertical diffusion-cells system. The fresh rat skin (pretreated with oleic acid for 1 hour) was used as the transport membrane separating the donor and the acceptor phase, which was filled with phosphate-buffered-saline pH 7.4. During 30h, samples were collected and analyzed using HPLC method. Four compartmental models were proposed, i.e. models with one (model 1) or two (model 2) lag-compartment(s) either with a zero-order (model A) or a first- order (model B) drug input from donor to the skin. WinSAAM was used to evaluate the models based on the parameters: 1) visual goodness of fit (GOF); and 2) Corrected Akaike's Information Criterion (AICc). Both the GOF and AICc evaluations indicated model 2-A as the best model describing losartan transdermal transport. The model suggested that after reaching the upper layer of skin at a constant rate, losartan transport was split into two flows. Both flows are transited in two separate lagcompartments before reaching into the acceptor phase. http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/16TransdermalLosartanModelingLag-compartmentWinSAAM |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Akhmad Kharis Nugroho Annas Binnarjo Arief Rahman Hakim Yunita Ermawati |
spellingShingle |
Akhmad Kharis Nugroho Annas Binnarjo Arief Rahman Hakim Yunita Ermawati COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO Indonesian Journal of Pharmacy Transdermal Losartan Modeling Lag-compartment WinSAAM |
author_facet |
Akhmad Kharis Nugroho Annas Binnarjo Arief Rahman Hakim Yunita Ermawati |
author_sort |
Akhmad Kharis Nugroho |
title |
COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO |
title_short |
COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO |
title_full |
COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO |
title_fullStr |
COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO |
title_full_unstemmed |
COMPARTMENTAL MODELING APPROACH OF LOSARTAN TRANSDERMAL TRANSPORT IN VITRO |
title_sort |
compartmental modeling approach of losartan transdermal transport in vitro |
publisher |
Universitas Gadjah Mada |
series |
Indonesian Journal of Pharmacy |
issn |
2338-9427 2338-9486 |
publishDate |
2014-01-01 |
description |
Development of losartan in transdermal formulation is
important due to its low oral bioavailability. Optimal transdermal
formulation requires transport mechanism understanding. This
study was aimed to develop and evaluate compartmental
modeling of losartan transdermal transport in vitro to fulfil this
demand. Losartan solution (10g/L in 20% propylene glycol) was
filled into the acceptor phase of a vertical diffusion-cells system.
The fresh rat skin (pretreated with oleic acid for 1 hour) was
used as the transport membrane separating the donor and the
acceptor phase, which was filled with phosphate-buffered-saline
pH 7.4. During 30h, samples were collected and analyzed using
HPLC method. Four compartmental models were proposed, i.e.
models with one (model 1) or two (model 2) lag-compartment(s)
either with a zero-order (model A) or a first- order (model B)
drug input from donor to the skin. WinSAAM was used to
evaluate the models based on the parameters: 1) visual
goodness of fit (GOF); and 2) Corrected Akaike's Information
Criterion (AICc). Both the GOF and AICc evaluations indicated
model 2-A as the best model describing losartan transdermal
transport. The model suggested that after reaching the upper
layer of skin at a constant rate, losartan transport was split into
two flows. Both flows are transited in two separate lagcompartments
before reaching into the acceptor phase. |
topic |
Transdermal Losartan Modeling Lag-compartment WinSAAM |
url |
http://indonesianjpharm.farmasi.ugm.ac.id/index.php/3/article/view/16 |
work_keys_str_mv |
AT akhmadkharisnugroho compartmentalmodelingapproachoflosartantransdermaltransportinvitro AT annasbinnarjo compartmentalmodelingapproachoflosartantransdermaltransportinvitro AT ariefrahmanhakim compartmentalmodelingapproachoflosartantransdermaltransportinvitro AT yunitaermawati compartmentalmodelingapproachoflosartantransdermaltransportinvitro |
_version_ |
1725265486354055168 |